Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Norman

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Expert Opinion on Investigational Drugs|May 6, 2016
Investigational Bruton's tyrosine kinase inhibitors for the treatment of rheumatoid arthritisPeter Norman
Pharmaceutical Patent Analyst|April 19, 2016
Humira: the impending patent battles over adalimumab biosimilarsPeter Norman
Current Opinion in Investigational Drugs (London, England : 2000)|May 22, 2002
Tipifarnib (Janssen Pharmaceutica)Peter Norman
Drug News & Perspectives|April 5, 2003
Novel Protease InhibitorsPeter Norman
Current Opinion in Investigational Drugs (London, England : 2000)|September 5, 2002
Atrasentan AbbottPeter Norman
Idrugs : the Investigational Drugs Journal|July 17, 2003
Medical chemistry in Eastern England--14th symposium: 10 April 2003, Hatfield, UKPeter Norman
Current Opinion in Investigational Drugs (London, England : 2000)|June 18, 2003
SomatoKine. InsmedPeter Norman
Expert Opinion on Therapeutic Patents|May 10, 2011
Boehringer Ingleheim's selective glucocorticoid receptor agonist development candidate: evaluation of WO2010141331, WO2010141332 and WO2010141333Peter Norman
Expert Opinion on Therapeutic Patents|February 11, 2010
1-acyl-4-benzyl-2,5-transdimethyl-piperazine CCR1 antagonistsPeter Norman
Expert Opinion on Investigational Drugs|January 21, 2015
Investigational p38 inhibitors for the treatment of chronic obstructive pulmonary diseasePeter Norman
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Expert Opinion on Investigational Drugs|May 6, 2016
Investigational Bruton's tyrosine kinase inhibitors for the treatment of rheumatoid arthritisPeter Norman
Pharmaceutical Patent Analyst|April 19, 2016
Humira: the impending patent battles over adalimumab biosimilarsPeter Norman
Current Opinion in Investigational Drugs (London, England : 2000)|May 22, 2002
Tipifarnib (Janssen Pharmaceutica)Peter Norman
Drug News & Perspectives|April 5, 2003
Novel Protease InhibitorsPeter Norman
Current Opinion in Investigational Drugs (London, England : 2000)|September 5, 2002
Atrasentan AbbottPeter Norman
Idrugs : the Investigational Drugs Journal|July 17, 2003
Medical chemistry in Eastern England--14th symposium: 10 April 2003, Hatfield, UKPeter Norman
Current Opinion in Investigational Drugs (London, England : 2000)|June 18, 2003
SomatoKine. InsmedPeter Norman
Expert Opinion on Therapeutic Patents|May 10, 2011
Boehringer Ingleheim's selective glucocorticoid receptor agonist development candidate: evaluation of WO2010141331, WO2010141332 and WO2010141333Peter Norman
Expert Opinion on Therapeutic Patents|February 11, 2010
1-acyl-4-benzyl-2,5-transdimethyl-piperazine CCR1 antagonistsPeter Norman
Expert Opinion on Investigational Drugs|January 21, 2015
Investigational p38 inhibitors for the treatment of chronic obstructive pulmonary diseasePeter Norman
Pageof 9